Cargando…

Comparison of standardized uptake values between (99m)Tc-HDP SPECT/CT and (18)F-NaF PET/CT in bone metastases of breast and prostate cancer

BACKGROUND: Despite recent technological advances allowing for quantitative single-photon emission computed tomography (SPECT), quantitative SPECT has not been widely used in the clinical practice. The aim of this study is to evaluate the feasibility of quantitative SPECT for measuring metastatic bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arvola, Samuli, Jambor, Ivan, Kuisma, Anna, Kemppainen, Jukka, Kajander, Sami, Seppänen, Marko, Noponen, Tommi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346696/ https://www.ncbi.nlm.nih.gov/pubmed/30680469 http://dx.doi.org/10.1186/s13550-019-0475-z

Ejemplares similares

Detection of prostate cancer bone metastases with fast whole-body (99m)Tc-HMDP SPECT/CT using a general-purpose CZT system
por: Arvola, Samuli, et al.
Publicado: (2022)

Quantitative [(99m)Tc]Tc-MDP SPECT/CT correlated with [(18)F]NaF PET/CT for bone metastases in patients with prostate cancer
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Clinical impact of 99mTc-HDP SPECT/CT imaging as standard workup for foot and ankle osteoarthritis
por: van Hasselt, AJ, et al.
Publicado: (2023)

Prospective comparison of (18)F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
por: Malaspina, Simona, et al.
Publicado: (2021)

(99m)Tc-HDP bone scintigraphy and (18)F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer
por: Wondergem, Maurits, et al.
Publicado: (2017)

The Role of Nuclear Medicine Imaging with (18)F-FDG PET/CT, Combined (111)In-WBC/(99m)Tc-Nanocoll, and (99m)Tc-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study
por: Aleksyniene, Ramune, et al.
Publicado: (2022)

(18)F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
por: Ferrari, Cristina, et al.
Publicado: (2020)

Comparison of Bone Metastases between (18)F-NaF PET/CT, (18)F-NaF PET, and Planar (99m)Tc-MDP Bone Scintigraphy in Patients with Newly Diagnosed Nasopharyngeal Carcinoma
por: Wang, Dong, et al.
Publicado: (2022)

Maximum standardized uptake value of foot SPECT/CT using Tc-99m HDP in patients with accessory navicular bone as a predictor of surgical treatment
por: Bae, Sungwoo, et al.
Publicado: (2019)

(99m)Tc-Sestamibi/(123)I Subtraction SPECT/CT in Parathyroid Scintigraphy: Is Additional Pinhole Imaging Useful?
por: Tunninen, Virpi, et al.
Publicado: (2017)

The feasibility of [(18)F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
por: Laasik, Maren, et al.
Publicado: (2020)

Molecular Imaging with (18)F-FDG PET/CT and (99m)Tc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata
por: Holzgreve, Adrien, et al.
Publicado: (2021)

Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT
por: Kupitz, Dennis, et al.
Publicado: (2021)

The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019)

Comparison of (18) F-NaF Imaging, (99m) Tc-MDP Scintigraphy, and (18) F-FDG for Detecting Bone Metastases
por: Dadgar, Habibollah, et al.
Publicado: (2022)

Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
por: Liepe, Knut, et al.
Publicado: (2022)

The Clinical Impact of Using (18)F-FDG-PET/CT in the Diagnosis of Suspected Vasculitis: The Effect of Dose and Timing of Glucocorticoid Treatment
por: Taimen, Kirsi, et al.
Publicado: (2019)

(18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients
por: Beheshti, Mohsen, et al.
Publicado: (2018)

The role of 18F–NaF PET/CT in metastatic bone disease
por: Araz, Mine, et al.
Publicado: (2015)

Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population
por: Ramsay, Stuart C., et al.
Publicado: (2018)

Quantification of (99m)Tc-DPD concentration in the lumbar spine with SPECT/CT
por: Cachovan, Michal, et al.
Publicado: (2013)

(99m)Tc-Ethambutol Scan with SPECT/CT in Knee Joint Tuberculosis
por: Kalra, Simran, et al.
Publicado: (2022)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

Can the function of the tubarial glands be evaluated using [(99m)Tc]pertechnetate SPECT/CT, [(18)F]FDG PET/CT, and [(11)C]methionine PET/CT?
por: Matsusaka, Yohji, et al.
Publicado: (2021)

How to combine CTA, (99m)Tc-WBC SPECT/CT, and [(18)F]FDG PET/CT in patients with suspected abdominal vascular endograft infections?
por: Lauri, Chiara, et al.
Publicado: (2023)

Prevalence of exclusive lower extremity metastases at (18)F-NaF PET/CT
por: Ordones, Monique Beraldo, et al.
Publicado: (2015)

Comparison of early F-18 Florbetaben PET/CT to Tc-99m ECD SPECT using voxel, regional, and network analysis
por: Kwon, Soo Jin, et al.
Publicado: (2021)

(90)Y SPECT/CT quantitative study and comparison of uptake with pretreatment (99 m)Tc‐MAA SPECT/CT in radiomicrosphere therapy
por: Debebe, Senait Aknaw, et al.
Publicado: (2019)

(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma
por: Mosci, Camila, et al.
Publicado: (2020)

Comparative study of (18)F-DCFPyL PET/CT and (99m)Tc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer
por: Hu, Xiongjian, et al.
Publicado: (2023)

Utility of (99m)Tc-MDP SPECT-CT for the diagnosis of sesamoiditis as cause of metatarsalgia
por: Sharma, Punit, et al.
Publicado: (2012)

Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
por: Szumowski, Piotr, et al.
Publicado: (2019)

Ectopic Submandibular Parathyroid Adenoma by Tc-99m Sestamibi SPECT/CT Localization
por: Ng, Fung Him, et al.
Publicado: (2020)

The joint use of (99m)Tc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning
por: Rodríguez-Fraile, Macarena, et al.
Publicado: (2021)

[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020)

Is dual-phase SPECT/CT with (99m)Tc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?
por: Lee, Suk Hyun, et al.
Publicado: (2020)

Prospective study evaluating the relative sensitivity of (18)F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and (99m)Tc-MDP bone scintigraphy, using an adaptive trial design
por: Gerety, E. L., et al.
Publicado: (2015)

Complementary findings on (18)F-FDG PET/CT and (18)F-NaF PET/CT in a patient with Erdheim-Chester disease
por: Sabino, Daniela, et al.
Publicado: (2017)

The role of (99m)Tc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with (99m)Tc-MIBI planar scintigraphy and ultrasonography
por: Jiang, Shu-Qin, et al.
Publicado: (2020)

Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device
por: Gnesin, Silvano, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7r76iempuopgcpkbe9cutdt51v